![Jürg Pfister](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jürg Pfister
Fondatore presso Theron Pharmaceuticals, Inc.
Profilo
Jürg Pfister is the founder and currently holds the position of Director at Theron Pharmaceuticals, Inc., which was founded in 2008.
Dr. Pfister's former job titles include Director-Chemical Process Development at CV Therapeutics, Inc., Vice President-Medical Chemistry at ARYx Therapeutics, Inc., Senior Researcher at CoMentis, Inc., Principal at Syntex, Inc., and Senior Research Scientist at Roche Bioscience.
Dr. Pfister obtained a doctorate degree from the Swiss Federal Institute of Technology.
Posizioni attive di Jürg Pfister
Società | Posizione | Inizio |
---|---|---|
Theron Pharmaceuticals, Inc.
![]() Theron Pharmaceuticals, Inc. BiotechnologyHealth Technology Theron Pharmaceuticals, Inc. provides treatments for COPD and asthma. It is a biotechnology company, develops long acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. The firm’s product TRN-157, a preclinical development therapy focuses on treating chronic obstructive pulmonary disease and severe asthma. The company was founded by M. Venkatraman, Xiaoming Zhang and Jurg Pfister in 2008 and is headquartered in Sunnyvale, CA. | Fondatore | 01/01/2008 |
Precedenti posizioni note di Jürg Pfister
Società | Posizione | Fine |
---|---|---|
CV Therapeutics, Inc.
![]() CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Corporate Officer/Principal | - |
Syntex, Inc. | Corporate Officer/Principal | - |
ARYX THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Roche Bioscience
![]() Roche Bioscience Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Bioscience is a company that discovers and develops prescription drugs. The company is based in Palo Alto, CA. | Direttore Tecnico/Scientifico/R&S | - |
CoMentis, Inc.
![]() CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formazione di Jürg Pfister
Swiss Federal Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ARYX THERAPEUTICS, INC. | Health Technology |
Aziende private | 5 |
---|---|
CV Therapeutics, Inc.
![]() CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Theron Pharmaceuticals, Inc.
![]() Theron Pharmaceuticals, Inc. BiotechnologyHealth Technology Theron Pharmaceuticals, Inc. provides treatments for COPD and asthma. It is a biotechnology company, develops long acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. The firm’s product TRN-157, a preclinical development therapy focuses on treating chronic obstructive pulmonary disease and severe asthma. The company was founded by M. Venkatraman, Xiaoming Zhang and Jurg Pfister in 2008 and is headquartered in Sunnyvale, CA. | Health Technology |
CoMentis, Inc.
![]() CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Syntex, Inc. | Miscellaneous |
Roche Bioscience
![]() Roche Bioscience Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Bioscience is a company that discovers and develops prescription drugs. The company is based in Palo Alto, CA. | Health Technology |
- Borsa valori
- Insiders
- Jürg Pfister